No Picture
News

Profusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen

Next-Generation Wireless Device May Enable Telehealth And Remote Patient Monitoring in the Future

EMERYVILLE, Calif., Jan. 28, 2020 /PRNewswire/ — Profusa, a digital health company that is pioneering the next generation of personalized medicine, to… […]

No Picture
News

Profusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen

Next-Generation Wireless Device May Enable Telehealth And Remote Patient Monitoring in the Future

EMERYVILLE, Calif., Jan. 28, 2020 /PRNewswire/ — Profusa, a digital health company that is pioneering the next generation of personalized medicine, to… […]

No Picture
News

National Cancer Center Japan Launches Multi-Center Randomized Trial Using Signatera(TM) MRD Testing in Stage II-III Colorectal Cancer

Pivotal Study of 1500 Patients Could Lead to Change in Practice Guidelines

SAN CARLOS, Calif., Jan. 15, 2020 /PRNewswire/ — Today Natera, Inc. (NASDAQ: NTRA) announced an agreement with the National Cancer Center (NCC) Japan to launch the CIRCULATE-… […]

No Picture
News

Earlens Announces Partnership with Verily to Develop Next-Generation Capabilities for Earlens® Contact Hearing Solution

MENLO PARK, Calif., Jan. 13, 2020 /PRNewswire/ — Earlens Corporation, a medical technology company that has created the world’s first nonsurgical hearing solution that directly vibrates the eardrum, announced today that they have entered into a str… […]